SVP of Clinical Development (Neurology)

Dario Mirski, MD

Prior to joining the pharmaceutical industry, Dario was a clinician with a productive career in research in Alzheimer’s Disease and other neuropsychiatric disorders  He has spent the last 20 years in a variety of leadership positions at multinational companies including Novartis, Chugai, Sanofi, Otsuka and Bayer.From 2001-2010, Dario worked in clinical development roles at Novartis, Chugai, and Sanofi.  From 2010 to now, he has held increasingly broad roles in medical affairs at Otsuka, Bayer, and Livanova.  Across all these positions he has managed large groups of multinational individuals in multiple therapeutic areas Dario is a Board Certified Psychiatrist that also obtained added qualifications in Geriatric Psychiatry as per the American Board of Psychiatry and Neurology having trained at  the Mount Sinai School of Medicine and the Medical University of South Carolina.